Halozyme Therapeutics, Inc. - HALO

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
09/22/2025 10b5-1	09/23/2025	Labrosse Nicole SVP, CHIEF FINANCIAL OFFICER CFO	Sell	-2,227 @ $77.95	($173,584.49)	22,079	(-9.16%)	Direct